Listed

Rhythm Pharmaceuticals, Inc.

RYTMNasdaqCIK 1649904HealthcareFiscal year ends Dec 31

Reports and events: 174 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Rhythm Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2024-04-0318:18 ETSC 13D/AOwnership report, active investor, amended0001193125-24-086172
2024-04-0117:25 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-24-041970
2024-03-2017:51 ETSC 13DOwnership report, active investor0001193125-24-072901
2024-02-2916:46 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001104659-24-029417
2024-02-2916:05 ET10-KAnnual reportPeriod 2023-12-310001558370-24-002181
2024-02-2207:01 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-24-026303
2024-01-0407:15 ET8-K7.01 Regulation FD disclosure0001104659-24-001141
2024-01-0407:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events0001104659-24-001139
2023-12-1816:16 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001104659-23-126873
2023-12-0616:30 ET8-K8.01 Other events0001104659-23-123990
2023-11-0816:30 ET10-QQuarterly reportPeriod 2023-09-300001558370-23-018291
2023-11-0707:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-23-114996
2023-08-2116:30 ET8-K8.01 Other events0001104659-23-093945
2023-08-0807:32 ET8-K5.02 Departure or appointment of officers or directors0001104659-23-088604
2023-08-0317:22 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-23-087375
2023-08-0116:27 ET10-QQuarterly reportPeriod 2023-06-300001558370-23-012739
2023-08-0107:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-23-086034
2023-06-2216:47 ET8-K5.07 Shareholder vote results0001104659-23-073809
2023-05-0216:30 ET10-QQuarterly reportPeriod 2023-03-310001558370-23-007675
2023-05-0207:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-23-054774
2023-04-2717:08 ETDEF 14AProxy statementPeriod 2023-06-210001104659-23-051469
2023-03-2918:51 ETSC 13D/AOwnership report, active investor, amended0001072613-23-000270
2023-03-1014:46 ET8-K8.01 Other events0001104659-23-031097
2023-03-0117:27 ET10-KAnnual reportPeriod 2022-12-310001558370-23-002613
2023-03-0107:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-23-026995
2023-01-0916:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-23-002258
2022-11-0814:06 ET10-QQuarterly reportPeriod 2022-09-300001558370-22-016818
2022-11-0807:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-115675
2022-11-0316:55 ET8-K1.02 Termination of a material agreement0001104659-22-114457
2022-09-1516:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001104659-22-100433
2022-08-0316:18 ET10-QQuarterly reportPeriod 2022-06-300001558370-22-011888
2022-08-0207:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-084960
2022-06-1617:11 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001104659-22-071971
2022-06-1016:30 ET8-K5.07 Shareholder vote results0001104659-22-070152
2022-05-0315:27 ET10-QQuarterly reportPeriod 2022-03-310001558370-22-006790
2022-05-0307:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-055004
2022-04-2816:40 ETDEF 14AProxy statementPeriod 2022-06-080001104659-22-052338
2022-04-0608:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-22-043012
2022-03-0115:53 ET10-KAnnual reportPeriod 2021-12-310001558370-22-002543
2022-03-0115:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-22-028609
2021-12-0817:08 ET8-K1.01 Entry into a material agreement0001104659-21-147685
2021-11-0214:13 ET10-QQuarterly reportPeriod 2021-09-300001558370-21-014043
2021-11-0207:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-132636
2021-09-0216:15 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure0001104659-21-112483
2021-08-0315:41 ET10-QQuarterly reportPeriod 2021-06-300001558370-21-009963
2021-08-0307:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-099155
2021-06-1416:04 ET8-K5.07 Shareholder vote results0001104659-21-080758
2021-05-0308:54 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001104659-21-059747
2021-05-0308:36 ET10-QQuarterly reportPeriod 2021-03-310001558370-21-005475
2021-04-2716:06 ETDEF 14AProxy statementPeriod 2021-06-090001104659-21-055591

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 3, 2026, 19:08 ET. Listed shows no prices and gives no investment advice.